All stocks Β· PAR
PD

Par Drugs And Chemicals Limited

PAR NSE Drug Manufacturers - Specialty & Generic Healthcare

Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide U…

ISIN INE04LG01015
Listed 16 Sep 2021
Quarters tracked 13
Filings 10 docs

About

Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, magnesium aluminometasilicate, magnesium aluminosilicate-USP, magnesium oxide light, magnesium oxide heavy, magnesium aluminium hydrate, hydrotalcite, and synthetic aluminium silicate. It offers fine chemicals, such as precipitated silica, sodium aluminium silicate, amorphous aluminium hydroxide, Alusil, PARSIL-HT, aluminium hydroxide magnesium carbonate co-dried gel, magnesium aluminium silicate hydrated (pharma), and magnesium aluminium silicate hydrated (agro). It also exports its products. Par Drugs and Chemicals Limited was founded in 1982 and is based in Vadodara, India.

Key Metrics

as of Sep 2026
Market Cap193 Cr
P/E13.30
Div Yield0.00 %
Book Valueβ‚Ή91.00
52w Highβ‚Ή180.00
52w Lowβ‚Ή78.00
Face Valueβ‚Ή10.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 31.28 19.61 29.34 28.66 26.05 22.33 21.38 34.66 22.61 22.82 24.00 25.89 22.93
Expenses 24.91 18.17 23.29 22.60 22.49 19.90 19.95 23.25 18.37 16.72 18.77 18.53 18.79
Operating Profit 6.37 1.44 6.05 6.06 3.56 2.43 1.43 11.41 4.24 6.10 5.23 7.36 4.14
OPM % 20.36 7.34 20.62 21.14 13.67 10.88 6.69 32.92 18.75 26.73 21.79 28.43 18.05
Other Income 0.94 0.36 1.33 0.48 1.84 0.79 0.27 1.02 0.07 -0.05 0.23 0.05 0.01
Depreciation 0.96 0.93 0.93 0.94 0.90 0.92 0.91 0.91 0.90 0.89 0.87 0.85 0.83
Interest 0.02 0.04 0.01 0.05 0.02 0.02 0.01 0.03 0.02 0.05 0.02 0.03 0.02
Profit before tax 6.33 0.83 6.44 5.55 4.48 2.28 0.78 11.49 3.39 5.11 4.57 6.53 3.30
Tax % 25.59 -3.61 25.47 25.59 25.67 27.63 24.36 25.15 25.07 27.20 25.16 25.27 25.15
Net Profit 4.71 0.85 4.80 4.13 3.33 1.65 0.58 8.60 2.53 3.72 3.42 4.89 2.47
EPS in Rs 3.83 0.69 3.90 3.36 2.71 1.34 0.47 6.99 2.06 3.02 2.78 3.97 2.01

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 104.00101.0096.0096.0075.0061.0056.0046.0042.0049.0033.0033.00
Expenses 87.0081.0073.0078.0059.0045.0046.0038.0034.0040.0026.0026.00
Operating Profit 17.0020.0023.0018.0016.0016.009.008.008.008.007.007.00
OPM % 17.0019.0024.0019.0022.0026.0017.0018.0019.0017.0022.0022.00
Other Income 4.002.000.000.000.002.000.000.000.000.000.000.00
Interest 0.000.000.000.000.001.001.002.002.002.004.004.00
Depreciation 4.004.003.003.003.003.003.003.003.003.003.002.00
Profit before tax 17.0018.0020.0015.0013.0015.006.003.003.003.001.001.00
Tax % 24.0026.0026.0025.0027.0021.0021.0024.0042.0042.0058.0027.00
Net Profit 13.0013.0014.0011.009.0012.005.003.002.002.000.001.00
EPS in Rs 10.6510.8611.789.217.499.443.872.792.783.430.781.65
Dividend Payout % 0.000.000.000.000.000.0032.000.000.000.000.000.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 12.0012.0012.0012.0012.006.006.004.003.003.003.003.00
Reserves 100.0087.0073.0059.0048.0046.0034.0025.0012.0011.009.009.00
Borrowings 0.000.000.000.000.008.006.0012.0029.0031.0036.0038.00
Other Liabilities 17.0020.0016.0018.0019.0016.0013.0011.0010.0012.0010.009.00
Total Liabilities 129.00119.00102.0089.0079.0076.0060.0051.0054.0056.0058.0059.00
Fixed Assets 36.0039.0041.0038.0034.0030.0034.0036.0039.0042.0043.0045.00
CWIP 1.000.000.000.000.005.001.000.000.000.000.000.00
Investments 27.0025.000.000.000.000.000.000.000.000.000.000.00
Other Assets 65.0055.0060.0050.0044.0042.0025.0015.0015.0014.0015.0013.00
Total Assets 129.00119.00102.0089.0079.0076.0060.0051.0054.0056.0058.0059.00

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 16.0016.0020.0013.008.0012.008.002.004.009.007.009.00
Cash from Investing Activity -2.00-25.00-6.00-7.00-3.000.00-1.000.00-1.00-2.000.000.00
Cash from Financing Activity 0.000.000.000.00-10.002.001.00-2.00-4.00-8.00-5.00-9.00
Net Cash Flow 14.00-9.0014.006.00-5.0014.007.000.000.00-1.001.00-1.00
Free Cash Flow 14.0015.0014.006.004.0012.006.002.004.007.006.009.00
CFO/OP % 125.00106.00108.0097.0066.0098.0090.0034.0059.00116.0091.00127.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 42.0060.0052.0065.0090.0075.0081.0067.0075.0061.0081.0083.00
Inventory Days 45.0058.0045.0049.0060.0050.0045.0081.0083.0069.00158.00111.00
Days Payable 69.00104.0058.0073.00135.00112.0096.0094.00107.00135.00183.00184.00
Cash Conversion Cycle 19.0015.0040.0040.0014.0013.0030.0055.0051.00-5.0057.0010.00
Working Capital Days 31.0039.0040.0050.0061.0024.0039.0013.00-26.00-46.0066.0061.00
ROCE % 17.0018.0025.0023.0022.0025.0016.0012.0011.0012.009.0010.00

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 73.41 73.41 73.41 73.37 73.37 73.37 73.37 73.37 74.21 74.21 74.21 74.21
FIIs 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.09 0.32 0.07 0.07 0.00
DIIs 0.09 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05 0.00 0.00
Public 26.51 26.59 26.59 26.63 26.63 26.63 26.63 26.54 25.47 25.68 25.73 25.79
No. of Shareholders 12,782 13,222 13,761 14,280 14,887 15,472 17,189 8,757 8,022 7,403 7,020 5,902

Corporate Actions

5 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Other 23 Dec 2024 23 Dec 2024 β€” β€” Extra Ordinary General Meeting
Other 13 Sep 2024 β€” β€” β€” Annual General Meeting
Other 08 Sep 2023 β€” β€” β€” Annual General Meeting
Other 01 Sep 2022 β€” β€” β€” Annual General Meeting
Dividend 22 Nov 2021 23 Nov 2021 β€” 1.25

Announcements

5 filings
  • Copy of Newspaper Publication
    05 Sep 2026 5 Sep - Par Drugs will hold its 27th AGM on 26 September 2026; newspaper notice issued for e-voting.
  • Updates
    01 Sep 2026 1 Sep - 27th AGM on 26 September 2026; FY2025-26 annual report and notice shared.
  • Appointment
    22 Aug 2026 22 Aug - Board approved 27th AGM on 26 Sep 2026, auditor appointments, and higher CEO/MD remuneration.
  • Outcome of Board Meeting
    22 Aug 2026 22 Aug - Board approved 27th AGM on 26 Sept 2026, auditor appointments, and remuneration increases for key executives.
  • Shareholders meeting
    22 Aug 2026 22 Aug - 27th AGM on 26 Sept 2026; e-voting 22-25 Sept; directors’ remuneration and reappointment proposals.